212 related articles for article (PubMed ID: 19860642)
1. Targeting sarcomas: novel biological agents and future perspectives.
Mahalingam D; Mita A; Sankhala K; Swords R; Kelly K; Giles F; Mita MM
Curr Drug Targets; 2009 Oct; 10(10):937-49. PubMed ID: 19860642
[TBL] [Abstract][Full Text] [Related]
2. Soft-tissue and bone sarcomas.
Scurr M; Judson I
Cancer Chemother Biol Response Modif; 2005; 22():591-604. PubMed ID: 16110630
[No Abstract] [Full Text] [Related]
3. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
Nakano K; Takahashi S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
[TBL] [Abstract][Full Text] [Related]
4. [Targeted therapies in soft-tissue and visceral sarcomas].
Emile JF
Ann Pathol; 2009 Nov; 29 Spec No 1():S81-2. PubMed ID: 19887262
[No Abstract] [Full Text] [Related]
5. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
Todd R; Lunec J
Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
[TBL] [Abstract][Full Text] [Related]
6. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
[TBL] [Abstract][Full Text] [Related]
7. Wild-type p53 gene transfection in human cultured sarcomas: effect of CDDP.
Endo K; Kuratate I; Watanabe M; Yoshida H; Teshima R; Osaki M; Ito H
Oncol Rep; 2001; 8(3):637-42. PubMed ID: 11295094
[TBL] [Abstract][Full Text] [Related]
8. The value of adjuvant chemotherapy in the management of sarcomas in children.
Donaldson SS
Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapy in bone and soft tissue sarcoma in children and adolescents.
Thompson PA; Chintagumpala M
Curr Oncol Rep; 2012 Apr; 14(2):197-205. PubMed ID: 22302601
[TBL] [Abstract][Full Text] [Related]
10. Novel pathways and molecular targets for the treatment of sarcoma.
Frith AE; Hirbe AC; Van Tine BA
Curr Oncol Rep; 2013 Aug; 15(4):378-85. PubMed ID: 23661264
[TBL] [Abstract][Full Text] [Related]
11. The role of mTOR inhibitors for treatment of sarcomas.
Mita MM; Tolcher AW
Curr Oncol Rep; 2007 Jul; 9(4):316-22. PubMed ID: 17588357
[TBL] [Abstract][Full Text] [Related]
12. Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions.
Aranha O; Agulnik M
Expert Opin Ther Targets; 2008 Feb; 12(2):197-207. PubMed ID: 18208368
[TBL] [Abstract][Full Text] [Related]
13. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
Aragon-Ching JB; Maki RG
Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
[TBL] [Abstract][Full Text] [Related]
14. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
Riedel RF
Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
[TBL] [Abstract][Full Text] [Related]
15. Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?
Blay JY; Cassier PA; Ray-Coquard I
Eur J Cancer; 2011 Sep; 47 Suppl 3():S385-8. PubMed ID: 21944026
[No Abstract] [Full Text] [Related]
16. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.
Wunder JS; Czitrom AA; Kandel R; Andrulis IL
J Natl Cancer Inst; 1991 Feb; 83(3):194-200. PubMed ID: 1988704
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic targets in soft tissue sarcoma.
Demicco EG; Maki RG; Lev DC; Lazar AJ
Adv Anat Pathol; 2012 May; 19(3):170-80. PubMed ID: 22498582
[TBL] [Abstract][Full Text] [Related]
18. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
Sethi TK; Keedy VL
Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
[TBL] [Abstract][Full Text] [Related]
19. Novel treatment strategies for soft tissue sarcoma.
Kasper B; Gil T; D'Hondt V; Gebhart M; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):9-15. PubMed ID: 17141519
[TBL] [Abstract][Full Text] [Related]
20. Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas.
Mita MM; Gong J; Chawla SP
Expert Rev Clin Pharmacol; 2013 Sep; 6(5):465-82. PubMed ID: 23971829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]